Tag: weight gain

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clinically meaningful weight reductionsSubstantial improvements in insulin resistance were also...

Fat Burner For Men Launched Over the Counter in USA – PhenQ Medically Accredited Thermogenic Fat Burning Supplement for Men

PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.

PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsWeight gain

SIGMA AI Closes on Investment from Trading Technologies to Build TT AI and Innovation Hub

African Sickle Cell News & World Report Pays Tribute to Global SCD Icons and Tackles Taboos in July-September 2025 Edition

Supervisory Board of Cabka nominates Mark Letterie for appointment as Chief Financial Officer

Tag: weight gain

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

Fat Burner For Men Launched Over the Counter in USA – PhenQ Medically Accredited Thermogenic Fat Burning Supplement for Men

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us